These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 23404436)

  • 1. Flare up of ulcerative colitis during pregnancy treated by adsorptive granulocyte and monocyte apheresis: therapeutic outcomes in three pregnant patients.
    Takahashi H; Sugawara K; Sugimura M; Iwabuchi M; Mano Y; Ukai K; Tadokoro K
    Arch Gynecol Obstet; 2013 Aug; 288(2):341-7. PubMed ID: 23404436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of granulocyte/monocyte apheresis therapy for active ulcerative colitis.
    Kanke K; Nakano M; Hiraishi H; Terano A
    Dig Liver Dis; 2004 Dec; 36(12):811-7. PubMed ID: 15646427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
    Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
    Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting clinical and endoscopic efficacies of selective leucocytapheresis for ulcerative colitis.
    Yamamoto T; Saniabadi AR; Maruyama Y; Umegae S; Matsumoto K
    Dig Liver Dis; 2007 Jul; 39(7):626-33. PubMed ID: 17532273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan.
    Hibi T; Sameshima Y; Sekiguchi Y; Hisatome Y; Maruyama F; Moriwaki K; Shima C; Saniabadi AR; Matsumoto T
    Dig Liver Dis; 2009 Aug; 41(8):570-7. PubMed ID: 19211314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of granulocyte and monocyte adsorption apheresis for ulcerative colitis: a meta-analysis.
    Yoshino T; Nakase H; Minami N; Yamada S; Matsuura M; Yazumi S; Chiba T
    Dig Liver Dis; 2014 Mar; 46(3):219-26. PubMed ID: 24268950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis.
    Suzuki Y; Yoshimura N; Fukuda K; Shirai K; Saito Y; Saniabadi AR
    Dig Dis Sci; 2006 Nov; 51(11):2031-8. PubMed ID: 17004123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
    Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ulcerative colitis and granulocyte-monocyte-apheresis: safety and efficacy of maintenance therapy during pregnancy.
    D'Ovidio V; Meo D; Gozer M; Bazuro ME; Vernia P
    J Clin Apher; 2015 Feb; 30(1):55-7. PubMed ID: 25181523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.
    Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S;
    Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.
    Yamamoto T; Umegae S; Kitagawa T; Yasuda Y; Yamada Y; Takahashi D; Mukumoto M; Nishimura N; Yasue K; Matsumoto K
    Aliment Pharmacol Ther; 2004 Oct; 20(7):783-92. PubMed ID: 15379839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic efficacy of leukocytapheresis in a pregnant woman with severe active ulcerative colitis.
    Okada H; Makidono C; Takenaka R; Hiraoka S; Fujiwara A; Kato J; Kawahara Y; Kawamoto H; Mizuno M; Shiratori Y
    Digestion; 2006; 74(1):15-8. PubMed ID: 16940730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Granulocyte/Monocyte Apheresis in Steroid-Dependent Active Ulcerative Colitis with Insufficient Response or Intolerance to Immunosuppressants and/or Biologics [the ART Trial]: 12-week Interim Results.
    Dignass A; Akbar A; Hart A; Subramanian S; Bommelaer G; Baumgart DC; Grimaud JC; Cadiot G; Makins R; Hoque S; Bouguen G; Bonaz B
    J Crohns Colitis; 2016 Jul; 10(7):812-20. PubMed ID: 26818659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: a multicenter study.
    Shimoyama T; Sawada K; Hiwatashi N; Sawada T; Matsueda K; Munakata A; Asakura H; Tanaka T; Kasukawa R; Kimura K; Suzuki Y; Nagamachi Y; Muto T; Nagawa H; Iizuka B; Baba S; Nasu M; Kataoka T; Kashiwagi N; Saniabadi AR
    J Clin Apher; 2001; 16(1):1-9. PubMed ID: 11309823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adacolumn leucocytapheresis for ulcerative colitis: clinical and endoscopic features of responders and unresponders.
    Sacco R; Tanaka T; Yamamoto T; Bresci G; Saniabadi AR
    Expert Rev Gastroenterol Hepatol; 2015 Mar; 9(3):327-33. PubMed ID: 25160857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications.
    Tanaka T; Sugiyama S; Goishi H; Kajihara T; Akagi M; Miura T
    BMC Gastroenterol; 2013 Aug; 13():130. PubMed ID: 23961883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy, safety and cost analyses in ulcerative colitis patients undergoing granulocyte and monocyte adsorption or receiving prednisolone.
    Tominaga K; Nakano M; Hoshino M; Kanke K; Hiraishi H
    BMC Gastroenterol; 2013 Mar; 13():41. PubMed ID: 23452668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study.
    Bresci G; Parisi G; Mazzoni A; Scatena F; Capria A
    Dig Liver Dis; 2007 May; 39(5):430-4. PubMed ID: 17379588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte adsorptive apheresis for pediatric patients with ulcerative colitis.
    Tomomasa T; Kobayashi A; Kaneko H; Mika S; Maisawa S; Chino Y; Syou H; Yoden A; Fujino J; Tanikawa M; Yamashita T; Kimura S; Kanoh M; Sawada K; Morikawa A
    Dig Dis Sci; 2003 Apr; 48(4):750-4. PubMed ID: 12741466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.